​

Funding Round

Series A - Alpheus Medical

Series A - Alpheus Medical

Investment Firm

Overview

Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.

Announced Date

Nov 17, 2021

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Action Potential Venture Capital

Action Potential Venture Capital

Action Potential Venture Capital is a early_stage_venture and late_stage_venture and private_equity and venture firm.

OrbiMed

OrbiMed

OrbiMed is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

5

Investor Name
Participant InvestorNational Brain Tumor Society
Participant InvestorBrightEdge Fund
Participant InvestorOrbiMed
Participant InvestorAction Potential Venture Capital
Participant InvestorSV Health Investors

Round Details and Background

Alpheus Medical raised $16000000 on 2021-11-17 in Series A

Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 17, 2021
Series A - Alpheus Medical
5-16.0M
Nov 10, 2022
Series A - Alpheus Medical
5-14.0M

Recent Activity

There is no recent news or activity for this profile.